Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efbemalenograstim Alfa Injection for Ovarian or Cervical Cancer Receiving Chemotherapy Regimen	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorder	Recruiting	Phase 2	2024-05-07		NCT06251947

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	88
Shandong University	50

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Qilu Hospital of Shandong University	Jinan	China	138
Qingdao Central Hospital, The Second Affiliated Hospital of Medical College of Qingdao University,	Qingdao	China	1
Shanxi Provincial Cancer Hospital	Taiyuan	China	5
Xiangya Hospital, Central South University,	Changsha	China	1
Zhejiang Cancer Hospital	Hangzhou	China	84
Zhongda Hospital, School of Medicine, Southeast University	Nanjing	China	1